{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:35:59Z","timestamp":1772076959114,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Natural Science Foundation of China (CN)","award":["81071710"],"award-info":[{"award-number":["81071710"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12032-016-0864-3","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T17:49:21Z","timestamp":1487008161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-\u03b1"],"prefix":"10.1007","volume":"34","author":[{"given":"Lijia","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"864_CR1","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2174\/092986712800099767","volume":"19","author":"TE Schmid","year":"2012","unstructured":"Schmid TE, Multhoff G. Radiation-induced stress proteins-the role of heat shock proteins (HSP) in anti-tumorresponses. Curr Med Chem. 2012;19:1765\u201370.","journal-title":"Curr Med Chem"},{"key":"864_CR2","first-page":"453","volume":"2014","author":"F Pasi","year":"2014","unstructured":"Pasi F, Paolini A, Nano R, Di Liberto R, Capelli E. Effects of single or combined treatments with radiation and chemotherapy on survival and danger signals expression in glioblastoma cell lines. Bio Med Res. 2014;2014:453\u201397.","journal-title":"Bio Med Res"},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0360-3016(99)00202-3","volume":"45","author":"J Handschel","year":"1999","unstructured":"Handschel J, Prott FJ, Sunderk\u00f6tter C, Metze D, Meyer U, et al. Irradiation induces increase of adhesion molecules and accumulation of beta2-integrin-expressing cells in humans. Int J Radiat Oncol Biol Phys. 1999;45:475\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","volume":"180","author":"AA Lugade","year":"2008","unstructured":"Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, et al. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J Immunol. 2008;180:3132\u20139.","journal-title":"J Immunol"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00262-013-1474-y","volume":"63","author":"B Frey","year":"2014","unstructured":"Frey B, Rubner Y, Kulzer L, Werthmoller N, Weiss EM, et al. Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunol Immunother. 2014;63:29\u201336.","journal-title":"Cancer Immunol Immunother"},{"key":"864_CR6","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2174\/1381612023394089","volume":"8","author":"EJ Friedman","year":"2002","unstructured":"Friedman EJ. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des. 2002;8:1765\u201380.","journal-title":"Curr Pharm Des"},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1158\/0008-5472.CAN-04-1525","volume":"64","author":"CT Garnett","year":"2004","unstructured":"Garnett CT, Palena C, Chakraborty M, Tsang KY, Schlom J, et al. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res. 2004;64:7985\u201394.","journal-title":"Cancer Res"},{"key":"864_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1748-717X-8-7","volume":"8","author":"F Mantel","year":"2013","unstructured":"Mantel F, Flentje M, Guckenberger M. Stereotactic body radiation therapy in there-irradiation situation-a review. Radiat Oncol. 2013;8:7\u201320.","journal-title":"Radiat Oncol"},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.seminoncol.2012.02.006","volume":"39","author":"JW Hodge","year":"2012","unstructured":"Hodge JW, Ardiani A, Farsaci B, Kwilas AR, Gameiro SR. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors. Semin Oncol. 2012;39:323\u201339.","journal-title":"Semin Oncol"},{"issue":"17","key":"864_CR10","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1158\/0008-5472.CAN-15-3567","volume":"76","author":"R Serre","year":"2016","unstructured":"Serre R, Benzekry S, Padovani L, Meille C, Andre N, et al. Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy. Cancer Res. 2016;76(17):4931\u201340.","journal-title":"Cancer Res"},{"issue":"13","key":"864_CR11","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1158\/0008-5472.CAN-15-2644","volume":"76","author":"ZS Morris","year":"2016","unstructured":"Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, et al. In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments. Cancer Res. 2016;76(13):3929\u201341.","journal-title":"Cancer Res"},{"issue":"7","key":"864_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00262-015-1771-8","volume":"65","author":"A Derer","year":"2016","unstructured":"Derer A, Frey B, Fietkau R, Gaipl US. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors. Cancer Immunol Immunother. 2016;65(7):779\u201386.","journal-title":"Cancer Immunol Immunother"},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coi.2014.01.005","volume":"27","author":"KJ Radford","year":"2014","unstructured":"Radford KJ, Tullett KM, Lahoud MH. Dendritic cells and cancer immunotherapy. Curr Opin Immunol. 2014;27:26\u201332.","journal-title":"Curr Opin Immunol"},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4110\/in.2012.12.6.269","volume":"12","author":"S Baek","year":"2012","unstructured":"Baek S, Lee SJ, Kim MJ, Lee H. Dendritic cell (DC) vaccine in mouse lung cancer minimal residual model; comparison of monocyte-derived DC vs. hematopoietic stem cell derived-DC. Immune Netw. 2012;12:269\u201376.","journal-title":"Immune Netw"},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00262-014-1558-3","volume":"63","author":"S Lint Van","year":"2014","unstructured":"Van Lint S, Wilgenhof S, Heirman C, Corthals J, Breckpot K, et al. Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula. Cancer Immunol Immunother. 2014;63:959\u201367.","journal-title":"Cancer Immunol Immunother"},{"key":"864_CR16","first-page":"165","volume":"11","author":"F Wimmers","year":"2014","unstructured":"Wimmers F, Schreibelt G, Sk\u00f6ld AE, Figdor CG, De Vries IJ, et al. Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets. Front Immunol. 2014;11:165\u201377.","journal-title":"Front Immunol"},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11060-014-1635-7","volume":"21","author":"MK Hunn","year":"2015","unstructured":"Hunn MK, Bauer E, Wood CE, Gasser O, Dzhelali M, et al. Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme. J Neurooncol. 2015;21:319\u201329.","journal-title":"J Neurooncol"},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/CJI.0000000000000054","volume":"37","author":"J Rossowska","year":"2014","unstructured":"Rossowska J, Pajtasz-Piasecka E, Anger N, Wojas-Turek J, Kicieli\u0144ska J, et al. Cyclophosphamide and IL-12-transduced DCs enhance the antitumor activity of tumor antigen-stimulated DCs and reduce Tregs and MDSCs number. J Immunother. 2014;37:427\u201339.","journal-title":"J Immunother"},{"key":"864_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5021\/ad.2014.26.1.53","volume":"26","author":"JW Byun","year":"2014","unstructured":"Byun JW, Lee HS, Song SU, Lee SW, Kim SK, et al. Combined treatment of murine fibrosarcoma with chemotherapy (Paclitaxel), radiotherapy, and intratumoral injection of dendritic cells. Ann Dermatol. 2014;26:53\u201360.","journal-title":"Ann Dermatol"},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","volume":"180","author":"AA Lugade","year":"2008","unstructured":"Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, et al. Radiation-induced IFN-\u03b3 production within the tumor microenvironment influences antitumor immunity. J Immunol. 2008;180:3132\u20139.","journal-title":"J Immunol"},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/CJI.0b013e318163628c","volume":"31","author":"S Teitz-Tennenbaum","year":"2008","unstructured":"Teitz-Tennenbaum S, Li Q, Okuyama R, Davis MA, Sun R, et al. Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy. J Immunother. 2008;31:345\u201358.","journal-title":"J Immunother"},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-8722-2-6","volume":"2","author":"X Ao","year":"2009","unstructured":"Ao X, Zhao L, Davis MA, Lubman DM, Lawrence TS, et al. Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol. 2009;2:6\u201318.","journal-title":"J Hematol Oncol"},{"key":"864_CR23","doi-asserted-by":"publisher","first-page":"e106423","DOI":"10.1371\/journal.pone.0106423","volume":"9","author":"EJ Lee","year":"2014","unstructured":"Lee EJ, Park HJ, Lee IJ, Kim WW, Ha SJ, et al. Inhibition of IL-17A suppresses enhanced-tumor growth in low dose pre-irradiated tumor beds. PLoS ONE. 2014;9:e106423.","journal-title":"PLoS ONE"},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2005.06.032","volume":"63","author":"S Demaria","year":"2005","unstructured":"Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys. 2005;63:655\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"864_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409\u201325.","journal-title":"Nat Rev Cancer"},{"key":"864_CR26","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-07-0472","volume":"13","author":"L Strauss","year":"2007","unstructured":"Strauss L, Bergmann C, Szczepanski M, Gooding W, Johnson JT, et al. A unique subset of CD4+ CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-\u03b21 mediates suppression in the tumor microenvironment. Clin Cancer Res. 2007;13:4345\u201354.","journal-title":"Clin Cancer Res"},{"key":"864_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.canlet.2014.10.019","volume":"356","author":"E Ahn","year":"2015","unstructured":"Ahn E, Kim H, Han KT, Sin JI. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells\u2019 antigen presentation to Ag-specific CTLs in a colon cancer model. Cancer Lett. 2015;356:676\u201385.","journal-title":"Cancer Lett"},{"key":"864_CR28","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","volume":"181","author":"S Matsumura","year":"2008","unstructured":"Matsumura S, Wang B, Kawashima N, Braunstein S, Badura M, et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol. 2008;181:3099\u2013107.","journal-title":"J Immunol"},{"key":"864_CR29","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.ejca.2011.12.009","volume":"48","author":"S Song","year":"2012","unstructured":"Song S, Wang Y, Wang J, Lian W, Liu S, et al. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs 1-silenced and sustained antigen expressing DCs. Eur J Cancer. 2012;48:2252\u20139.","journal-title":"Eur J Cancer"},{"key":"864_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.imlet.2009.09.003","volume":"127","author":"A Lin","year":"2010","unstructured":"Lin A, Schildknecht A, Nguyen LT, Ohashi PS. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett. 2010;127:77\u201384.","journal-title":"Immunol Lett"},{"key":"864_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1471-4906(01)01860-9","volume":"22","author":"M Larsson","year":"2001","unstructured":"Larsson M, Fonteneau JF, Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends Immunol. 2001;22:141\u20138.","journal-title":"Trends Immunol"},{"key":"864_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1479-5876-12-211","volume":"12","author":"R Saenz","year":"2014","unstructured":"Saenz R, Futalan D, Leutenez L, Eekhout F, Fecteau JF, et al. TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant. J Transl Med. 2014;12:211.","journal-title":"J Transl Med"},{"key":"864_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4049\/jimmunol.182.3.1449","volume":"182","author":"T Chen","year":"2009","unstructured":"Chen T, Guo J, Han C, Yang M, Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol. 2009;182:1449\u201359.","journal-title":"J Immunol"},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","volume":"124","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Burnette B, Beckett M, Darga T, et al. Irradiation and anti\u2013PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014;124:687\u201395.","journal-title":"J Clin Invest"},{"key":"864_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1667\/RR13471.1","volume":"182","author":"A Filatenkov","year":"2014","unstructured":"Filatenkov A, Baker J, M\u00fcller AM, Ahn GO, Kohrt H, et al. Treatment of 4T1 Metastatic Breast cancer with combined hypofractionated irradiation and autologous T-cell infusion. Radiat Res. 2014;182:163\u20139.","journal-title":"Radiat Res"},{"key":"864_CR36","doi-asserted-by":"publisher","first-page":"e27403","DOI":"10.4161\/onci.27403","volume":"3","author":"P Balermpas","year":"2014","unstructured":"Balermpas P, R\u00f6del F, Weiss C, R\u00f6del C, Fokas E. Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer. Oncoimmunology. 2014;3:e27403.","journal-title":"Oncoimmunology"},{"key":"864_CR37","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1084\/jem.20130762","volume":"210","author":"PD Bos","year":"2013","unstructured":"Bos PD, Plitas G, Rudra D, Lee SY, Rudensky AY. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J Exp Med. 2013;210:2435\u201346.","journal-title":"J Exp Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-016-0864-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-016-0864-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T20:27:55Z","timestamp":1494275275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-016-0864-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1007\/s12032-016-0864-3","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]},"article-number":"44"}}